107 related articles for article (PubMed ID: 15253248)
1. Inhibition of intimal hyperplasia by direct thrombin inhibitors in an animal vein bypass model.
Mureebe L; Turnquist SE; Silver D
Ann Vasc Surg; 2004 Mar; 18(2):147-50. PubMed ID: 15253248
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis.
LaMuraglia GM; Klyachkin ML; Adili F; Abbott WM
J Vasc Surg; 1995 Jun; 21(6):882-90; discussion 889-90. PubMed ID: 7776467
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of vein cuffed anastomoses is not mechanical in origin.
Norberto JJ; Sidawy AN; Trad KS; Jones BA; Neville RF; Najjar SF; Sidawy MK; DePalma RG
J Vasc Surg; 1995 Apr; 21(4):558-64; discussion 564-6. PubMed ID: 7707561
[TBL] [Abstract][Full Text] [Related]
4. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model.
Bledsoe SL; Barr JC; Fitzgerald RT; Brown AT; Faas FH; Eidt JF; Moursi MM
Vasc Endovascular Surg; 2006; 40(1):49-57. PubMed ID: 16456606
[TBL] [Abstract][Full Text] [Related]
6. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
[TBL] [Abstract][Full Text] [Related]
7. Saratin, an inhibitor of collagen-platelet interaction, decreases venous anastomotic intimal hyperplasia in a canine dialysis access model.
Smith TP; Alshafie TA; Cruz CP; Fan CY; Brown AT; Wang Y; Eidt JF; Moursi MM
Vasc Endovascular Surg; 2003; 37(4):259-69. PubMed ID: 12894368
[TBL] [Abstract][Full Text] [Related]
8. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
9. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
10. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
[TBL] [Abstract][Full Text] [Related]
11. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
12. Cryoplasty of the venous anastomosis for prevention of intimal hyperplasia in a validated porcine arteriovenous graft model.
Huijbregts HJ; de Borst GJ; Veldhuis WB; Verhagen HJ; Velema E; Pasterkamp G; Moll FL; Blankestijn PJ; Hoefer IE
Eur J Vasc Endovasc Surg; 2010 May; 39(5):620-6. PubMed ID: 20153668
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of low molecular weight heparin.
Fletcher JP; Ao PY; Hawthorne WJ
ANZ J Surg; 2004 Sep; 74(9):793-6. PubMed ID: 15379813
[TBL] [Abstract][Full Text] [Related]
14. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
15. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
16. Influence of dexamethasone on intimal thickening in experimental vein graft.
Norman PE; House AK
Cardiovasc Surg; 1993 Dec; 1(6):724-8. PubMed ID: 8076131
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neointimal hyperplasia by a specific thrombin inhibitor.
Wahlgren CM; Frebelius S; Swedenborg J
Scand Cardiovasc J; 2004 Mar; 38(1):16-21. PubMed ID: 15204242
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
19. L-arginine polymers inhibit the development of vein graft neointimal hyperplasia.
Kown MH; Yamaguchi A; Jahncke CL; Miniati D; Murata S; Grunenfelder J; Koransky ML; Rothbard JB; Robbins RC
J Thorac Cardiovasc Surg; 2001 May; 121(5):971-80. PubMed ID: 11326242
[TBL] [Abstract][Full Text] [Related]
20. Suppressors of oxygen metabolites fail to reduce vein graft intimal hyperplasia.
Gates JD; Hirsch GM; Karnovsky MJ
Arch Surg; 1995 Sep; 130(9):976-80. PubMed ID: 7661683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
